OpenAI asks the US to lead global standards for self-improving AI
THE SO WHAT
A major lab explicitly asking the US to lead on standards for self-improving AI moves RSI from sci-fi into the policy backlog. If you’re building advanced training or agent systems, assume future licensing, reporting, and capability thresholds—start logging experiments and safety controls at a level regulators could eventually inspect.
READ THE SOURCE
MORE FROM THE WIRE
Applied AIRingg’s AI agents resolve up to 65% of customer calls with OpenAI
If GPT-5.6 can handle 65% of calls across channels at 90% lower unit cost than GPT-4.1, the economics of front-line support are tilting from augmentation to replacement. CX leaders should be modeling what happens when the marginal cost of an incremental support interaction rounds toward zero and quality becomes the only real constraint.
Applied AIAmericans Are a Lot More Worried About AI Than the Rest of the World
Higher U.S. anxiety about AI is the cost of being the test market—users here are seeing both upside and failure modes first. If you’re building for global scale, expect more friction, scrutiny, and policy drag in the U.S. than in most other markets and plan your rollout and comms accordingly.
Applied AIThe Pope’s AI Guy Is Worried About ‘Cartel’ Behavior Among Big Labs
When a Vatican advisor starts talking about cartel dynamics in AI, the antitrust and governance conversation has clearly escaped the tech echo chamber. Large buyers should anticipate more scrutiny on exclusive deals and closed ecosystems and keep optionality in their model and infra choices.
Applied AIAnthropic’s biolab made a discovery it’s comparing to Crispr
If Claude can autonomously propose enzyme systems that biologists compare to CRISPR machinery, AI-assisted wet labs just moved from hype to pipeline. Biotech operators should assume model-guided discovery will compress early-stage timelines and rethink how they allocate human bench time versus compute.